Description
Formestaneisasteroidalandrogensubstratethatinhibitsaromatase.FormestaneisclinicallyusedtotreatER+breastcancer,asitinhibitsproductionofestrogens.
Formestaneisasteroidalandrogensubstratethatinhibitsaromatase.FormestaneisclinicallyusedtotreatER+breastcancer,asitinhibitsproductionofestrogens.
CasNo. | 566-48-3 |
---|---|
Purity | ≥98% |
Formula | C19H26O3 |
FormulaWt. | 302.41 |
ChemicalName | 4-Hydroxyandrost-4-ene-3,17-dione |
IUPACName | (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione |
Synonym | 4-OHA;Lentaron |
MeltingPoint | 199-202°C |
Solubility | Solubleinmethanol. |
Appearance | WhiteCrystallinePowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
MSDS | F5769MSDSPDF |
---|---|
InfoSheet | F5769InfoSheetPDF |
MillerWR.Aromataseinhibitors:mechanismofactionandroleinthetreatmentofbreastcancer.SeminOncol.2003Aug;30(4Suppl14):3-11.PMID:14513432.
DowsettM.Aromataseinhibition:basicconcepts,andthepharmacodynamicsofformestane.AnnOncol.1994;5Suppl7:S3-5.PMID:7873460.